Nelson B. Watts

Journal of Bone and Mineral Research · 2000–2015

A researcher in the Science corpus: 8 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Who trusts Nelson B. Watts overall

1. R. Baron
2. R. Russell

Papers from Nelson B. Watts's perspective

Ordered by how strongly the researchers Nelson B. Watts trusts endorse each paper. Same corpus, a different order for every researcher.

1. Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate (Journal of Bone and Mineral Research)
2. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. (Journal of the American Medical Association (JAMA))
3. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. (Journal of Pharmacology and Experimental Therapeutics)
4. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. (New England Journal of Medicine)
5. Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws (Annals of Internal Medicine)
6. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. (New England Journal of Medicine)
7. Risk of new vertebral fracture in the year following a fracture. (Journal of the American Medical Association (JAMA))
8. Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis (Journal of Bone and Mineral Research)
9. Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 (Journal of Bone and Mineral Research)
10. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. (Journal of Clinical Endocrinology and Metabolism)

Their papers

• The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (2007) — 1,245 citations
• Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy (2008) — 1,406 citations
• Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus (2015) — 1,288 citations
• The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group (2014) — 597 citations
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research (2007) — 1,652 citations
• Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study (2004) — 606 citations
• Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. (2003) — 1,259 citations
• A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. (2000) — 1,084 citations